The nation of Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) spanning five years because of the United States' demand for sensitive biological samples.
The decision became public following a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "unbalanced".
An official representative has since clarified that the United States was seeking biological samples for research and commercial purposes while was not willing to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged further talks to find a agreement suitable to both sides so the nation's critical HIV treatment initiative can continue.
Broader Implications
Zimbabwe's decision comes after a comparable case in Kenya, where a high court halted a similar health funding agreement following concerns were raised about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and accountability.
Based on statements, 16 nations in Africa have to date signed these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our nation would supply the basic resources for medical research with no assurance that the end products would be available to our population should a future pandemic arise."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its pursuit of bilateral deals were upending structures previously set up via the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This system is designed to ensure that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how future collaboration might be designed in a way that respects the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body stated it acknowledged the official position, but urged that negotiations must proceed considering a large portion of the nation's HIV programmes relied on foreign aid.
"In cases where technical issues exist, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
The halted deal emphasises the ongoing challenges between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.